Medtronic Inc has accepted that the defects in its security insulin pumps could help hackers control the device with a remote.

However, company officials have notified that the 200,000 diabetes patients who have been using the device should not worry as the risk of the cyber attack was near to the ground.

On Friday, the British medical devices company Smith & Nephew Plc., reported a 73% rise in third-quarter net profit and shared the anticipation that the market for replacement hips and knees is stabilizing.

Becton Dickinson & Co recorded a decent increase in profit for the fourth quarter at 12 per cent. The revenue for the quarter also rose by 5 per cent all due to the high sales in the diagnostic and medical unit of the company.

In a letter to physicians, Medtronic Inc. has warned that nearly 37,000 of its pacemakers, produced late 1990s onwards, could possibly have wiring defects due to which a malfunctioning of the medical equipment is quite possible.

In its endeavor to expand its growing diabetes business, the Minneapolis-based medical device maker Medtronic Inc. intends making 1,400 job-additions in the coming five-year period, at its new San Antonio, Texas-based customer support facility, scheduled to open late this summer.

The recent study has shown that a device placed in the heart is more effective in reducing risk of stroke due to a common heart-rhythm disorder as compared to anti-clotting drug.

U. S. Democrats on Thursday moved a legislation to overturn a 2008 ruling that protected medical device companies from being sued by patients over harm from their products that were approved by the Food and Drug Administration.

Baxa Corporation, a customer-focused medical device company, has informed that it has acquired ForHealth Technologies, Inc., a Florida-based healthcare robotics and software company, in a strategic expansion of its focus on health-system pharmacy automation and IV room productivity.

Minneapolis-headquartered Medtronic, Inc. has signed a definitive agreement to acquire CoreValve, Inc., developer of a transcatheter, transfemoral aortic valve replacement product.

Medtronic Inc’s implantable deep brain stimulator, Reclaim DBS Therapy, has received the FDA approval for facilitating the treatment process in severe cases of obsessive-compulsive disorder (OCD), in which drug and psychotherapy have been futile.